Dermata Therapeutics: Funding, Investors & Team (Sep 2026)
Dermata is a development-stage biotechnology company that focuses on making major advancements in the treatment of serious diseases treated by dermatologists. Its business strategy is to identify and develop innovative products that move into clinical trials to demonstrate efficacy and safety in a variety of diseases. They currently exploring the use of a unique botanical product with multiple proposed mechanisms of action in order to treat acne. It was founded in 2014 and headquartered in Encinitas, California.
Dermata Therapeutics has raised $4.4M across 2 funding rounds on record, the most recent an undisclosed round of $2.6M announced in Jan 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dermata Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Dermata Therapeutics Funding Rounds
Dermata Therapeutics raised $1.8M in an undisclosed round announced in May 2023.
1.7 years later, an undisclosed round of $2.6M was announced in Jan 2025.
Dermata Therapeutics Founders and Leadership Team
Contact details for the Dermata Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Dermata Therapeutics Funding Compared to Other Biotechnology Startups
Dermata Therapeutics' latest round of $2.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dermata Therapeutics in Biotechnology and Encinitas
Companies Similar to Dermata Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Dermata Therapeutics Funding FAQs
What does Dermata Therapeutics do?
Dermata is a development-stage biotechnology company that focuses on making major advancements in the treatment of serious diseases treated by dermatologists. Its business strategy is to identify and develop innovative products that move into clinical trials to demonstrate efficacy and safety in a variety of diseases. They currently exploring the use of a unique botanical product with multiple proposed mechanisms of action in order to treat acne. It was founded in 2014 and headquartered in Encinitas, California.
How much funding has Dermata Therapeutics raised?
Dermata Therapeutics has raised $4.4M across 2 rounds on record. The most recent is an undisclosed round of $2.6M announced in Jan 2025.
When did Dermata Therapeutics last raise funding?
Dermata Therapeutics' most recent funding round on record is an undisclosed round of $2.6M, announced in Jan 2025.
Who founded Dermata Therapeutics?
FundedIQ lists Gerry Proehl (Founder) at Dermata Therapeutics.
Where is Dermata Therapeutics headquartered?
Dermata Therapeutics is based in Encinitas, California, United States.
How many employees does Dermata Therapeutics have?
Dermata Therapeutics is in the 1-10 employee band.
How does Dermata Therapeutics' funding compare to other Biotechnology startups?
Dermata Therapeutics' latest round of $2.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Dermata Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dermata Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.